Iorio, Raffaele
 Distribuzione geografica
Continente #
NA - Nord America 3.176
EU - Europa 3.002
AS - Asia 1.008
AF - Africa 31
SA - Sud America 13
OC - Oceania 9
Continente sconosciuto - Info sul continente non disponibili 5
Totale 7.244
Nazione #
US - Stati Uniti d'America 3.153
DE - Germania 1.306
SE - Svezia 550
CN - Cina 434
SG - Singapore 284
IT - Italia 276
UA - Ucraina 267
IE - Irlanda 151
FR - Francia 138
IN - India 112
GB - Regno Unito 106
ID - Indonesia 92
FI - Finlandia 66
RU - Federazione Russa 64
TR - Turchia 35
BE - Belgio 33
CI - Costa d'Avorio 29
CA - Canada 20
JP - Giappone 14
CH - Svizzera 13
IR - Iran 11
NL - Olanda 9
AU - Australia 8
PL - Polonia 6
KR - Corea 5
A2 - ???statistics.table.value.countryCode.A2??? 4
BR - Brasile 4
CL - Cile 4
CZ - Repubblica Ceca 3
HK - Hong Kong 3
AT - Austria 2
BO - Bolivia 2
CO - Colombia 2
IL - Israele 2
IQ - Iraq 2
LK - Sri Lanka 2
LT - Lituania 2
MD - Moldavia 2
MY - Malesia 2
PT - Portogallo 2
RO - Romania 2
SA - Arabia Saudita 2
AR - Argentina 1
BD - Bangladesh 1
BG - Bulgaria 1
BZ - Belize 1
ES - Italia 1
EU - Europa 1
GR - Grecia 1
KG - Kirghizistan 1
KW - Kuwait 1
KZ - Kazakistan 1
LV - Lettonia 1
MM - Myanmar 1
MU - Mauritius 1
MX - Messico 1
NG - Nigeria 1
NZ - Nuova Zelanda 1
OM - Oman 1
PR - Porto Rico 1
TM - Turkmenistan 1
UZ - Uzbekistan 1
Totale 7.244
Città #
Chandler 670
Ashburn 331
Singapore 221
Jacksonville 197
Ann Arbor 179
Dublin 145
New York 133
San Mateo 130
Nanjing 102
Nürnberg 100
Jakarta 92
Dearborn 83
Woodbridge 83
Wilmington 67
Chicago 59
Houston 57
Marseille 49
Bremen 48
Cattolica 48
Boston 44
Moscow 42
Princeton 39
Lawrence 37
Milan 35
Redwood City 35
Brussels 33
Nanchang 33
Izmir 32
Los Angeles 31
Beijing 30
Redmond 30
Abidjan 29
Norwalk 28
Seattle 27
Hangzhou 24
Munich 24
Rome 21
Mountain View 20
Shenyang 20
Detroit 18
Pune 18
Boardman 17
Shanghai 17
University Park 17
Ottawa 16
Trieste 16
Monza 15
Changsha 14
Fairfield 14
Leawood 14
Tianjin 14
Hebei 12
Hefei 12
Kunming 9
Helsinki 8
Jiaxing 8
Zhengzhou 8
Cambridge 7
Guangzhou 7
Santa Clara 7
Washington 7
Indiana 6
Verona 6
Zurich 6
Buffalo 5
Falls Church 5
Fremont 5
Seoul 5
Andover 4
Berlin 4
Busto Arsizio 4
Costa Mesa 4
Florence 4
Fort Worth 4
Gunzenhausen 4
Jinan 4
Kraków 4
London 4
New Delhi 4
Ningbo 4
Paris 4
Renton 4
San Francisco 4
Simi Valley 4
Stockholm 4
São Paulo 4
Ardabil 3
Bern 3
Easton 3
Edinburgh 3
Gallup 3
Göppingen 3
Hounslow 3
Landshut 3
Millbury 3
Napoli 3
Nishikicho 3
Oggiono 3
Philadelphia 3
Sacramento 3
Totale 3.835
Nome #
Circulating CD56dim NK cells expressing perforin are increased in progressive multiple sclerosis 212
pSTAT1, pSTAT3, and T-bet as markers of disease activity in chronic inflammatory demyelinating polyradiculoneuropathy. 181
CD8(+) T Cells in Facioscapulohumeral Muscular Dystrophy Patients with Inflammatory Features at Muscle MRI 159
T-bet, pSTAT1 and pSTAT3 expression in peripheral blood mononuclear cells during pregnancy correlates with post-partum activation of multiple sclerosis. 155
T-bet and pSTAT1 expression in peripheral blood mononuclear cells from coeliac disease patients: new markers of disease activity 154
Multiple Sclerosis attacks triggered by hyperprolactinemia 153
Distinctive clinical and neuroimaging characteristics of longitudinally extensive transverse myelitis associated with aquaporin-4 autoantibodies 146
Acute necrotizing Encephalopathy during novel influenza A (H1N!) virus infection 140
Cerebellar degeneration associated with mGluR1 autoantibodies as a paraneoplastic manifestation of prostate adenocarcinoma 140
The effect of disease activity on leptin, leptin receptor and suppressor of cytokine signalling-3 expression in relapsing-remitting multiple sclerosis. 135
Poly-autoimmunity in patients with myasthenia gravis: A single-center experience 132
Refractory generalized seizures and cerebellar ataxia associated with anti-GAD antibodies responsive to immunosuppressive treatment. 127
Glucocorticoid treatment reduces T-bet and pSTAT1 expression in mononuclear cells from relapsing remitting multiple sclerosis patients. 126
A Case of Hemiabdominal Myoclonus 125
Increased expression of T-bet in circulating B cells from a patient with multiple sclerosis and celiac disease 120
Epstein-Barr virus antibodies in serum and cerebrospinal fluid from Multiple Sclerosis, Chronic Inflammatory Demyelinating Polyradiculoneuropathy and Amyotrophic Lateral 119
Assessment of neurological manifestations in hospitalized patients with COVID-19 116
Copper deficiency myelopathy: A report of two cases 114
A b3 type-thymoma in a 7-year-old child with myasthenia gravis 111
Overcoming challenges in the diagnosis and treatment of myasthenia gravis 111
Circulating CD8+CD56-Perforin+ T cells are increased in Multiple Sclerosis patients 110
Overcoming challenges in the diagnosis and treatment of myasthenia gravis 110
A machine-learning parsimonious multivariable predictive model of mortality risk in patients with Covid-19 108
Replay to Influenza A (H1N1) in cerebrospinal fluid sample and encephalopathy by Sandoval-Gutiérrez JM, Arcos M, Alva L, Volkow P, T Ferrari T, Quiñones F, Vázquez-Pérez J, Ormsby JE, Hanssen F, Reséndiz A, Alcántara P, Pérez Padilla R, Bautista E. 107
Remission of myasthenia gravis with MuSK antibodies during ruxolitinib treatment 103
Efficacy and safety of rituximab for myasthenia gravis: a systematic review and meta-analysis 102
CD8(+)Foxp3(+) T cells in peripheral blood of relapsing-remitting multiple sclerosis patients 101
Brainstem and spinal cord involvement in a paraneoplastic syndrome associated with anti-Yo antibody and breast cancer. 101
Increased CD4(+)CD25(+)Foxp3(+) T Cells in Peripheral Blood of Celiac Disease Patients: Correlation with Dietary Treatment. 99
Type 1 immune response in progressive Multiple Sclerosis 97
CD4+pSTAT3+ and CD8+T-bet+ T cells accumulate in peripheral blood during NZB treatment 96
Sleep disorder associated with antibodies to IgLON5: parasomnia or agrypnia? 93
3,4-Diaminopyridine may improve myasthenia gravis with MuSK antibodies 92
The persistency of high levels of pSTAT3 expression in circulating CD4+ T cells from CIS patients favors the early conversion to clinically defined multiple sclerosis. 91
Progressive multifocal leukoencephalopathy in a patient with Franklin disease and hypogammaglobulinemia. 90
IL17 and IFNgamma production by peripheral blood mononuclear cells from clinically isolated syndrome to secondary progressive multiple sclerosis. 90
Prognostic relevance of quantitative and longitudinal MOG antibody testing in patients with MOGAD: a multicentre retrospective study 89
Breastfeeding and multiple sclerosis 87
Teaching NeuroImages: Transient mutism associated with splenium lesion in capecitabine-induced leukoencephalopathy 86
Resolution of muscle inflammation after tumor removal in a woman with paraneoplastic dermatomyositis 84
Long-Lasting Rituximab-Induced Reduction of Specific—But Not Total—IgG4 in MuSK-Positive Myasthenia Gravis 83
SIADH in a patient with sensory ataxic neuropathy with anti-disialosyl antibodies (CANOMAD) 81
Distinct lymphocytes subsets in IgM-related neuropathy: clinical-immunological correlations 80
Post-Encephalitic Parkinsonism and Sleep Disorder Responsive to Immunological Treatment: A Case Report 80
A Case of Hemiabdominal Myoclonus 79
Myasthenia gravis with presynaptic neurophysiological signs: Two case reports and literature review 79
Multiple sclerosis attacks triggered by hyperprolactinemia 77
Clinical and immunological characteristics of the spectrum of GFAP autoimmunity: a case series of 22 patients 77
Glioblastoma in multiple sclerosis: a case report 76
Clinical characteristics and outcome of patients with autoimmune encephalitis: clues for paraneoplastic etiology 75
Efficacy and safety of rituximab therapy in neuromyelitis optica spectrum disorders: A systematic review and meta-analysis 74
Pattern of ocular involvement in myasthenia gravis with MuSK antibodies 74
Focal hyperhidrosis in tumefactive Multiple Sclerosis 73
Acetylcholine receptor antibody positivity rate in ocular myasthenia gravis: a matter of age? 73
Regulatory T cells fail to suppress CD4(+)T-bet(+) T cells in relapsing multiple sclerosis patients 72
Myasthenia gravis with antibodies to MuSK: an update 72
Lower motor neuron involvement in longitudinally extensive transverse myelitis with and without aquaporin-4 antibodies 71
Post-Encephalitic Parkinsonism and Sleep Disorder Responsive to Immunological Treatment: A Case Report 71
Imaging Features of Varicella Zoster Virus Cranial Multiple Mononeuropathies 70
The detection of neural autoantibodies in patients with antiepileptic-drug-resistant epilepsy predicts response to immunotherapy 69
Clinical features and outcome of patients with autoimmune cerebellar ataxia evaluated with the Scale for the Assessment and Rating of Ataxia 69
gc) Increased CD4+CD25+Foxp3+ T cells in peripheral blood of celiac disease patients: correlation with dietary treatment. 68
gc)Increased expression of T-bet in circulating B cells from a patient with multiple sclerosis and celiac disease 64
Gastrointestinal symptoms and digestive comorbidities in an Italian cohort of patients with COVID-19 64
gc) T-bet and pSTAT-1 expression in PBMC from coeliac disease patients: new markers of disease activity. 61
Movement disorders phenomenology in focal motor seizures 61
pSTAT1, pSTAT3, and T-bet expression in peripheral blood mononuclear cells from relapsing-remitting multiple sclerosis patients correlates with disease activity 57
Overcoming challenges in the diagnosis and treatment of myasthenia gravis 57
Tuberculous nephritis accompanying neuromyelitis optica: causal or coincidental association? 56
Neuromyelitis optica spectrum disorder as a paraneoplastic manifestation of lung adenocarcinoma expressing aquaporin-4 55
Nine syndrome 52
Controversies in Ocular Myasthenia Gravis 52
Toxic leukoencephalopathy after intravenous heroin injection: a case with clinical and radiological reversibility 49
Diagnostics of paraneoplastic neurological syndromes 43
Diagnostics of autoimmune encephalitis associated with antibodies against neuronal surface antigens 36
Management of antibody-mediated autoimmune encephalitis in adults and children: literature review and consensus-based practical recommendations 35
Myasthenia gravis associated with muscle-specific kinase antibodies in a patient treated with interleukin-17 inhibitor 31
A score that predicts aquaporin-4 IgG positivity in patients with longitudinally extensive transverse myelitis 27
Isolated Memory Loss in Anti-NMDAR Encephalitis 24
Immunotherapy improves sleep and cognitive impairment in anti-IgLON5 encephalopathy 20
Real-world application of the updated diagnostic criteria for paraneoplastic neurological syndromes 18
Clinical Reasoning: A 55-year-old woman presenting with ataxia and numbness 1 year after ileum resection 18
Pseudoperipheral tongue weakness 18
Myasthenia gravis: the changing treatment landscape in the era of molecular therapies 17
Paraneoplastic neurological syndromes 17
Grading the severity of autoimmune encephalitis: Advances and pitfalls 17
Clinical and neuroimaging characteristics of MOG autoimmunity in children with acquired demyelinating syndromes 17
Neuromyelitis optica and the evolving spectrum of autoimmune aquaporin-4 channelopathies 14
Teaching Video NeuroImage: Bilateral Eyelid Opening Apraxia in a Patient With Top of the Basilar Syndrome 14
A machine-learning parsimonious multivariable predictive model of mortality risk in patients with Covid-19 14
Clinically relevant increases in serum neurofilament light chain and glial fibrillary acidic protein in patients with Susac syndrome 9
Comorbidities rather than age affect medium-term outcome in octogenarian patients after total knee arthroplasty 8
Totale 7.380
Categoria #
all - tutte 28.644
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 28.644


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020694 0 0 0 0 105 110 101 17 84 63 150 64
2020/2021677 58 59 8 66 86 34 82 23 68 42 136 15
2021/2022794 75 47 24 74 41 18 22 101 36 61 121 174
2022/20231.819 196 243 143 300 97 223 96 156 238 50 49 28
2023/2024990 35 240 35 109 25 181 66 41 16 25 107 110
2024/2025429 36 79 143 78 93 0 0 0 0 0 0 0
Totale 7.380